Rating History for Lyell Immunopharma (LYEL) by Stifel

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/5/2026 Stephen Willey New Coverage Buy
(N/A)
36.00
(N/A)
13.60
(14.53)
6.84% Details